• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Cancer Therapeutics

Cancer Therapeutics

  1. Global Bladder Cancer Therapeutics & Diagnostics Market - Expected to Grow 3-5% by 2020 - Research and Markets

    Global Bladder Cancer Therapeutics & Diagnostics Market - Expected to Grow 3-5% by 2020 - Research and Markets

  2. MOLOGEN AG: First patient recruited in combination study with lefitolimod and Yervoy®

    MOLOGEN AG: First patient recruited in combination study with lefitolimod and Yervoy®

  3. Sprint Bioscience Enters into Collaboration with US Drug Development Company on Tumor Metabolism Program

    Sprint Bioscience Enters into Collaboration with US Drug Development Company on Tumor Metabolism Program

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.